PlainPharmaWatch

CMS Open Payments · Program Year 2024

McKesson Drug Company LLC

McKesson Drug Company LLC reported $30,670.49 in payments to 18 physicians and teaching hospitals across 18 transactions.

See the rankings → How this is sourced
$30.7K
Total payments
18
Transactions
18
Recipients
−$952.52
General Payments vs PY2023

McKesson Drug Company LLC reported $30,670.49 in payments to 18 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1465 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $1.7K per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

McKesson Drug Company LLC pairs modest payment volume with a concentrated payment pattern focused on a handful of top recipients.

#1465
of 1,925 companies
0.0%
of all US industry payments
0.7%
paid to its single top recipient
3
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

McKesson Drug Company LLC's CMS-reported General Payments decreased by $952.52 (−3.0%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: MCKESSON DRUG COMPANY LLCPY2023: MCKESSON DRUG COMPANY LLCPY2024: McKesson Drug Company LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$31.6KPY2024$30.7K
PY2023
$31,623.01
PY2024
$30,670.49

How McKesson Drug Company LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

McKesson Drug Company LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$30,670 24th percentile higher than 24% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). This entry sits in this band. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for McKesson Drug Company LLC

Rank #1465 of 1,925 companies in CMS Open Payments for 2024 belongs to McKesson Drug Company LLC, which reported $30,670.49 across 18 transactions to 18 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $1.7K per transaction and $1.7K per recipient.

"Charitable Contribution" leads the 3-category general-payment breakdown below at $29.0K (94.6% of the company's reported total, 4 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 3 types of general payments, McKesson Drug Company LLC's largest category was "Charitable Contribution" at $29.0K - 94.6% of the company's reported total.

How McKesson Drug Company LLC divides its payments

Top payment categories by total reported dollar volume

1. Charitable Contribution$29.0K2. Food and Beverage$1.3K3. Honoraria$407.00
Payment Type Amount Transactions
Charitable Contribution $29.0K 4
Food and Beverage $1.3K 13
Honoraria $407.00 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $29,407.00 (95.9%) of $30,670.49 in this company's General Payments records across 15 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for McKesson Drug Company LLC

The five named recipients with the highest reported General Payments from this company

Ochsner Clinic Foundation$20.0KYale-New Haven Hospital$5.0KKaleida Health$2.5KUams Medical Center$1.5KJoseph Ezra Glaser$407.00
  1. 1

    Ochsner Clinic Foundation

    $20,000.00 across 1 reported transactions

  2. 2

    Yale-New Haven Hospital

    $5,000.00 across 1 reported transactions

  3. 3

    Kaleida Health

    $2,500.00 across 1 reported transactions

  4. 4

    Uams Medical Center

    $1,500.00 across 1 reported transactions

  5. 5

    Joseph Ezra Glaser

    $407.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.7K. Average per recipient: $1.7K.

Total Amount

$30,670.49

Avg per Transaction

$1.7K

Avg per Recipient

$1.7K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

McKesson Drug Company LLC Share

0.0%

#1465 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to McKesson Drug Company LLC

Molli Surgical (us) Inc

$30.6K 185 recipients

RIWOspine, Inc.

$30.8K 63 recipients

Hubly Incorporated

$30.5K 4 recipients

Intelivation Technologies, LLC

$30.3K 43 recipients

Atlas Spine, Inc.

$31.3K 17 recipients

Vitrolife Inc.

$31.3K 38 recipients

Frequently Asked Questions

How much did McKesson Drug Company LLC pay to physicians and hospitals in 2024? ▾
McKesson Drug Company LLC made $30,670.49 in payments to physicians and hospitals in Program Year 2024, across 18 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from McKesson Drug Company LLC? ▾
Averaging $1.7K per recipient, McKesson Drug Company LLC's 2024 payments reached 18 physicians and teaching hospitals.
What types of payments did McKesson Drug Company LLC make? ▾
3 categories of general payment make up McKesson Drug Company LLC's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Charitable Contribution" at $29.0K, representing 94.6% of the company's reported total.
How does McKesson Drug Company LLC rank among pharmaceutical companies? ▾
McKesson Drug Company LLC ranks #1465 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from McKesson Drug Company LLC? ▾
In 2024, McKesson Drug Company LLC averaged $1.7K per transaction across 18 transactions to 18 recipients.
Where does the payment data for McKesson Drug Company LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download McKesson Drug Company LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.